| Literature DB >> 20429884 |
Fanny Calenge1, Pete Kaiser, Alain Vignal, Catherine Beaumont.
Abstract
Salmonellosis is a frequent disease in poultry stocks, caused by several serotypes of the bacterial species Salmonella enterica and sometimes transmitted to humans through the consumption of contaminated meat or eggs. Symptom-free carriers of the bacteria contribute greatly to the propagation of the disease in poultry stocks. So far, several candidate genes and quantitative trait loci (QTL) for resistance to carrier state or to acute disease have been identified using artificial infection of S. enterica serovar Enteritidis or S. enterica serovar Typhimurium strains in diverse genetic backgrounds, with several different infection procedures and phenotypic assessment protocols. This diversity in experimental conditions has led to a complex sum of results, but allows a more complete description of the disease. Comparisons among studies show that genes controlling resistance to Salmonella differ according to the chicken line studied, the trait assessed and the chicken's age. The loci identified are located on 25 of the 38 chicken autosomal chromosomes. Some of these loci are clustered in several genomic regions, indicating the possibility of a common genetic control for different models. In particular, the genomic regions carrying the candidate genes TLR4 and SLC11A1, the Major Histocompatibility Complex (MHC) and the QTL SAL1 are interesting for more in-depth studies. This article reviews the main Salmonella infection models and chicken lines studied under a historical perspective and then the candidate genes and QTL identified so far.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20429884 PMCID: PMC2873309 DOI: 10.1186/1297-9686-42-11
Source DB: PubMed Journal: Genet Sel Evol ISSN: 0999-193X Impact factor: 4.297
Infection models used in published studies of the genetic control of resistance to Salmonella in fowl
| Infection route | Cross type | ||||||
|---|---|---|---|---|---|---|---|
| MSAT | subcuta-neaous | 10 d | 10 d | ABR to SE vaccine | F2+BC | (low × high) ABR divergent inbred lines | [ |
| MSAT | subcuta-neaous | 10 d | 21 d | ABR to SE vaccine | F1 | Broiler outbred male × 3 inbred lines (2 MHC-congenic WL + Fay) | [ |
| QTL | oral | 1 w | 4/5 w | CSWB counts/caecal load | F2 | (N × 61) × (N × 61) layer inbred lines | [ |
| QTL | oral | 6 w | 2 w | CSWB counts/caecal load | BC | (N × 61) × 61 layer inbred lines | [ |
| QTL | oral | 2 w | 5 d | splenic load | BC | (61 × 15I) × 61 layer inbred lines | [ |
| CG | subcuta-neaous | 10 d | 11 d | ABR to SE vaccine | F2 | (Fay × WL) × (Fay × WL) | [ |
| CG | intra-oesophageal | 10 d | 21 d | ABR to SE vaccine | F1 | Broiler outbred male × 3 inbred lines (2 MHC-congenic WL + Fay) | [ |
| CG | intra-oesophageal | 1 d | 7/8 d | spleen and caecal loads | F8 | AIL (Broiler × Fay) × AIL (Broiler × inbred WL) | [ |
| CG | intravenous | 13 w | 3 d | spleen and liver loads | F1 | Egg-type commercial crosses | [ |
| CG | oral | peak of lay | 4 w | spleen load; number of contaminated organs | F1 | Egg-type commercial crosses | [ |
| CG | intra-muscular | 1 d | death or 2 w | survival rate | BC | (WlxC) × C | [ |
| CG | intra-muscular | 1 d | death or 2 w | survival rate | F0 | Inbred WL lines | [ |
| CG | intra-oesophageal | 1 d | 6/7 d | caecal and spleen loads | F1 | Broiler outbred male × 3 inbred lines (2 MHC-congenic WL + Fay) | [ |
| CG | intra-oesophageal | 1 d | 6 d | caecal and spleen loads | F8 | (Broiler × Fay) × AIL (Broiler × inbred WL) | [ |
| CG | oral | 3 w | 7 d | caecal load | F0 | 5 groups of meat type chicken | [ |
1 CG: candidate gene, MSAT: microsatellite
2 Animal age at infection or injection; d: day; w: week
3 Assessment time post inoculation (pi)
4ABR: antibody response; CSW: cloacal swab; SE: Salmonella Enteritidis
5 AIL: advanced intercross lines; Fay: Fayoumi; WL: White Leghorn
6 Reference
Physical and genetic positions of published loci for resistance to Salmonella in fowl.
| Locus name | Mb | Ref | ||||
|---|---|---|---|---|---|---|
| MSAT | ADL0160 | ABR to SE vaccine | 33 | 5.93 | [ | |
| QTL | - | CSWB counts (SE) | 85 | 33.57 | [ | |
| QTL | - | CSWB counts (ST) | 207 | 68.52 | [ | |
| MSAT | ADL0020 | ABR to SE vaccine | 286 | 94.16 | [ | |
| CG | Caecal load; ABR to SE vaccine | - | 113.90 | [ | ||
| MSAT | ADL0198 | ABR to SE vaccine | 458 | 171.74 | [ | |
| CG | caecal load (SE) | - | 186.92 | [ | ||
| QTL | - | CSWB counts (SE) | 87 | 26.93 | [ | |
| CG | Splenic load (SE) | - | 122.83 | [ | ||
| MSAT | MCW0051 | ABR to SE vaccine | 358 | 129.15 | [ | |
| MSAT | MCW0083 | ABR to SE vaccine | 51 | 13.99 | [ | |
| MSAT | MCW0024 | ABR to SE vaccine | 237 | - | [ | |
| CG | Caecal load (SE) | - | 18.29 | [ | ||
| CG | Caecal load (SE) | - | 20.54 | [ | ||
| CG | Gal13 | Caecal load (SE) | - | 110.20 | [ | |
| CG | Gal12 | Caecal load (SE) | - | 110.21 | [ | |
| CG | Gal11 | Caecal load (SE) | - | 110.21 | [ | |
| CG | Gal7 | ABR to SE vaccine | - | 110.25 | [ | |
| CG | Gal3 | ABR to SE vaccine | - | 110.26 | [ | |
| CG | Gal5 | Spleen load (SE) | - | 110.27 | [ | |
| CG | Spleen and caecal load (SE) | - | 9.67 | [ | ||
| CG | Caecal load (SE) | - | 55.26 | [ | ||
| QTL | - | CSWB counts (ST) | 100 | 36.10 | [ | |
| QTL | - | CSWB counts (SE) | 111 | 39.28 | [ | |
| QTL | Splenic load (ST) | 157 | 53.24 | [ | ||
| MSAT | ADL0298 | ABR to SE vaccine | 198 | 60.23 | [ | |
| CG | Caecal load (SE) | - | 40.87 | [ | ||
| MSAT | ADL0138 | ABR to SE vaccine | 56 | 10.09 | [ | |
| CG | Splenic and caecal loads (SE) | - | 13.02 | [ | ||
| CG | Survival rate (ST) | 80 | 23.91 | [ | ||
| MSAT | ADL301 | ABR to SE vaccine | 80 EL | 25.10 | [ | |
| QTL | - | Caecal load (SE); CSWB counts | 18 | 3.66 | [ | |
| CG | Caecal load | - | 8.17 | [ | ||
| QTL | - | Caecal load | 2 | 0.10 | [ | |
| CG | Splenic load (SE) | - | - | [ | ||
| CG | ABR to SE vaccine | - | 0.04 | [ | ||
| CG | ABR to SE vaccine | 0.04 | [ | |||
| CG | ABR to SE vaccine | 0.06 | [ | |||
| CG | Survival rate (ST) | - | 4.06 | [ | ||
| MSAT | ADL0293 | ABR to SE vaccine | 26 | 6.39 | [ | |
| CG | Caecal load | - | 0.64 | [ | ||
| CG | Caecal load | - | 9.17 | [ | ||
| CG | Splenic and caecal loads | - | 0.00 | [ | ||
| CG | Splenic and caecal loads | - | 2.35 | [ | ||
| CG | Splenic and caecal loads | - | 2.37 | [ | ||
| MSAT | LEI0135 | ABR to SE vaccine | 0 | 0.18 | [ | |
1Chromosome
2CG: candidate gene; MSAT: microsatellite
3ABR: antibody response; CSWB: cloacal swabs; ST: S. Typhimurium; SE: S. Enteritidis
4Physical positions were obtained by searching the Ensembl Genome Browser http://www.ensembl.org/index.html with the original Accession Number given by the authors. QTL positions were calculated according to physical positions of flanking molecular marker.
Figure 1Physical map of published loci for resistance to . Mapchart 2.1 software was used to draw this map [77]. Positions are indicated in Mb. QTL positions are indicated by plain black boxes to the right of chromosomes; their length was calculated to cover 20 cM centered on the QTL likelihood peak. ABR: antibody response; SE: Salmonella Enteritidis; ST: Salmonella Typhimurium.